about
Calciphylaxis: risk factors, diagnosis, and treatmentFibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolismCalcium Balance in Chronic Kidney Disease.Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney diseaseRunx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice.Effect of restricted protein diet supplemented with keto analogues in chronic kidney disease: a systematic review and meta-analysis.Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency.Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients.Effects of high glucose and high insulin concentrations on osteoblast function in vitro.Potential application of klotho in human chronic kidney disease.Skeletal findings in secondary hyperparathyroidism.The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case reportHistomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease.Bone-eating kidney disease.Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.The P2Y2 nucleotide receptor is an inhibitor of vascular calcification.Clear the Fog around Parathyroid Hormone Assays: What Do iPTH Assays Really Measure?Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients.Intestinal Phosphorus Absorption in Chronic Kidney Disease
P2860
Q28084969-685D8B0E-DFC2-420D-9E0D-EAB00B6C8904Q30544587-BB2095DC-649D-46CA-970F-FFFBF64AB3F6Q33720411-E188439B-15C5-4E77-82A5-1A2346AB19DAQ34939232-E1BEEE89-B578-49D6-88A2-3B1FCED0E5DFQ35792795-171278BE-568A-45C6-A5A1-72B9F6CCB294Q35856255-A5160A5F-3392-4580-A80D-A3AFA015100FQ36141100-B18C40BA-DC2B-4B5B-A641-98A7816E0640Q36941547-20EA3A6C-0D32-47A9-81ED-8E1A511DCAA3Q38991825-DFEDFA88-4A81-4097-9BEF-A75B4972C227Q39003568-C0EB9737-96B5-444A-8699-B2EBF3921B80Q42330037-C5E1A1B3-A834-435A-9388-65F32F7D1DD5Q42672060-16AA4053-AE6A-4B0C-846D-1A107DB88FD1Q43820704-907A11FC-CE7C-4CAB-A2A4-7B457CBEBDBFQ47134974-A2E53DAC-5714-47C8-B546-EAAC22B7ADDAQ47571217-2E1A554B-AE2A-4914-BF9D-DBAB631293BAQ49751552-BC894830-3067-4974-A28D-B9D2FEBDDEE7Q52673329-F0357A4D-5419-4A75-800A-ACE08290F96CQ55463750-591BB866-7B7C-4742-94A9-FB6E3B6F87F9Q58701703-289D6F7D-588B-4D81-9DC2-51D020C6D02E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CKD-mineral and bone disorder: core curriculum 2011.
@en
CKD-mineral and bone disorder: core curriculum 2011.
@nl
type
label
CKD-mineral and bone disorder: core curriculum 2011.
@en
CKD-mineral and bone disorder: core curriculum 2011.
@nl
prefLabel
CKD-mineral and bone disorder: core curriculum 2011.
@en
CKD-mineral and bone disorder: core curriculum 2011.
@nl
P2860
P1476
CKD-mineral and bone disorder: core curriculum 2011.
@en
P2093
Ranjani N Moorthi
Sharon M Moe
P2860
P304
P356
10.1053/J.AJKD.2011.08.009
P577
2011-10-21T00:00:00Z